
OrganiGram Holdings OGI
€ 1.21
0.7%
Geschäftsbericht 2024
hinzugefügt 27.12.2025
OrganiGram Holdings DIO 2011-2026 | OGI
DIO Jährlich OrganiGram Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 2.83 K | - | - | - | - | - |
Alle Zahlen in CAD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.83 K | 2.83 K | 2.83 K |
DIO anderer Aktien in der Arzneimittelhersteller
| Name | DIO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AcelRx Pharmaceuticals
ACRX
|
133 | - | 7.5 % | $ 6.35 M | ||
|
Agile Therapeutics
AGRX
|
82.7 | - | 10.11 % | $ 58.2 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
48.9 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
459 | - | - | $ 754 M | ||
|
Catalent
CTLT
|
71.9 | - | - | $ 11.5 B | ||
|
Eagle Pharmaceuticals
EGRX
|
149 | - | -39.89 % | $ 27.7 M | ||
|
Endo International plc
ENDP
|
100 | - | - | $ 28.9 M | ||
|
DURECT Corporation
DRRX
|
460 | - | - | $ 50.1 M | ||
|
Alimera Sciences
ALIM
|
58.7 | - | - | $ 142 M | ||
|
Athenex
ATNX
|
158 | - | -23.39 % | $ 1.76 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
366 | - | - | $ 2.06 B | ||
|
Evoke Pharma
EVOK
|
995 | - | - | $ 36.6 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
239 | $ 3.18 | 1.92 % | $ 44.7 M | ||
|
Cronos Group
CRON
|
221 | $ 2.57 | - | $ 1.33 B | ||
|
HEXO Corp.
HEXO
|
703 | - | 2.45 % | $ 38.1 M | ||
|
Bausch Health Companies
BHC
|
172 | $ 5.68 | -0.7 % | $ 2.07 B | ||
|
Harrow Health
HROW
|
65.1 | $ 37.94 | 2.27 % | $ 1.39 B | ||
|
Aurora Cannabis
ACB
|
1.35 K | $ 3.53 | 1.44 % | $ 86.3 M | ||
|
Canopy Growth Corporation
CGC
|
167 | $ 1.09 | 0.93 % | $ 117 M | ||
|
Jupiter Wellness
JUPW
|
80.2 | - | - | $ 33.6 M | ||
|
Lannett Company
LCI
|
127 | - | 1.15 % | $ 7.11 M | ||
|
Evolus
EOLS
|
71.3 | $ 4.44 | 2.54 % | $ 286 M | ||
|
Emergent BioSolutions
EBS
|
176 | $ 8.66 | 5.1 % | $ 443 M | ||
|
Tilray
TLRY
|
170 | $ 6.91 | 2.83 % | $ 4.27 B | ||
|
Organogenesis Holdings
ORGO
|
85.9 | $ 2.51 | 5.46 % | $ 330 M | ||
|
Pacira BioSciences
PCRX
|
246 | $ 23.75 | -1.29 % | $ 1.1 B | ||
|
Veru
VERU
|
179 | $ 2.42 | 1.68 % | $ 326 M | ||
|
PetIQ
PETQ
|
64.9 | - | 1.64 % | $ 400 M | ||
|
Viatris
VTRS
|
140 | $ 13.91 | 0.58 % | $ 16.7 B | ||
|
ProPhase Labs
PRPH
|
30.1 | - | - | $ 5.07 M | ||
|
cbdMD
YCBD
|
165 | $ 0.73 | -2.28 % | $ 3.15 M | ||
|
Assertio Holdings
ASRT
|
322 | $ 18.02 | - | $ 115 M | ||
|
Radius Health
RDUS
|
204 | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
49.1 | - | -4.76 % | $ 65.3 M | ||
|
OptiNose
OPTN
|
370 | - | - | $ 1.08 B | ||
|
PLx Pharma
PLXP
|
97.2 | - | -27.8 % | $ 2.56 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
117 | $ 2.18 | -7.23 % | $ 2.71 M | ||
|
Zomedica Corp.
ZOM
|
187 | - | -0.21 % | $ 98 M | ||
|
Rockwell Medical
RMTI
|
29.2 | $ 0.93 | -1.38 % | $ 33.5 M | ||
|
China Pharma Holdings
CPHI
|
166 | $ 0.63 | -3.05 % | $ 2.7 M | ||
|
TherapeuticsMD
TXMD
|
1.04 K | $ 2.11 | 2.93 % | $ 24.4 M |